ILK and infection: In contrast, in the immunocompetent neonatal mice, DENV replicates in the brains, induces neurological symptoms, such as seizure and paralysis, and results in death after infection, which makes it a feasible model for us to test the efficacy of blocking ILK as a therapeutic strategy.